Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 1
2020 5
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Physical Activity Modulating Lipid Metabolism in Gallbladder Diseases.
Shanmugam H, Molina Molina E, Di Palo DM, Faienza MF, Di Ciaula A, Garruti G, Wang DQH, Portincasa P. Shanmugam H, et al. Among authors: di palo dm. J Gastrointestin Liver Dis. 2020 Mar 13;29(1):99-110. doi: 10.15403/jgld-544. J Gastrointestin Liver Dis. 2020. PMID: 32176752 Free PMC article. Review.
Aging and nutrition. Paving the way to better health.
Molina-Molina E, Garruti G, Shanmugam H, Di Palo DM, Grattagliano I, Mastronuzzi T, Portincasa P. Molina-Molina E, et al. Among authors: di palo dm. Rom J Intern Med. 2020 Jun 1;58(2):55-68. doi: 10.2478/rjim-2020-0005. Rom J Intern Med. 2020. PMID: 32134741 Free article. Review.
Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver.
Shanmugam H, Di Ciaula A, Di Palo DM, Molina-Molina E, Garruti G, Faienza MF, vanErpecum K, Portincasa P. Shanmugam H, et al. Among authors: di palo dm. Eur J Clin Invest. 2021 Jul;51(7):e13597. doi: 10.1111/eci.13597. Epub 2021 May 25. Eur J Clin Invest. 2021. PMID: 34032283 Free PMC article.
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.
Cosola C, Rocchetti MT, di Bari I, Acquaviva PM, Maranzano V, Corciulo S, Di Ciaula A, Di Palo DM, La Forgia FM, Fontana S, De Angelis M, Portincasa P, Gesualdo L. Cosola C, et al. Among authors: di palo dm. Toxins (Basel). 2021 May 5;13(5):334. doi: 10.3390/toxins13050334. Toxins (Basel). 2021. PMID: 34063068 Free PMC article. Clinical Trial.